Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Sarepta Therapeutics, Inc. -- SRPT

Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against
Sarepta Therapeutics, Inc. -- SRPT

NEW YORK, Jan. 31, 2014 (GLOBE NEWSWIRE) -- Morgan & Morgan announces that a
class action has been filed in the United States District Court for the
District of Massachusetts, on behalf of all purchasers of Sarepta
Therapeutics, Inc. securities ("Sarepta" or "Company") (Nasdaq:SRPT) between
July 24, 2013 and November 12, 2013, inclusive (the "Class Period"), alleging
violations of the Securities Exchange Act of 1934.

If you purchased Sarepta during the Class Period, you may, no later than March
28, 2014, request that the Court appoint you lead plaintiff of the proposed
class. A lead plaintiff is a representative party that acts on behalf of other
class members in directing the litigation. Any member of the purported class
may move the Court to serve as lead plaintiff through counsel of their choice,
or may choose to do nothing and remain an absent class member.

If you want more information about the Sarepta Class Action Lawsuit please
contact George Pressly, Esq. at 1-800-631-6234 or
AskGeorge@morgansecuritieslaw.com.

The complaint alleges that Sarepta issued materially false or misleading
statements concerning, among other things: (1) the prospects of the Food and
Drug Administration's ("FDA") acceptance for consideration of a New Drug
Application ("NDA") for eteplirsen based on Sarepta's Phase IIb study data
set, and (2) the significance of that data set. On November 12, 2013, the FDA
informed Sarepta that its anticipated NDA filing for eteplirsen was premature.
Following this news, Sarepta's stock price fell $23.40, a decline of 64%, from
its closing price of $36.56 per share on November 11, 2013, to $13.16 per
share on November 12, 2013, on extraordinary volume.

About Morgan & Morgan

Morgan & Morgan is one of the nation's largest 200 law firms. In addition to
securities fraud, the firm also practices in the areas of antitrust, personal
injury, consumer protection, wage and hour, and product liability. All of the
Firm's legal endeavors are rooted in its core mission: provide investor and
consumer protection and always fight "for the people."

Attorney advertising.Prior results do not guarantee a similar outcome.

CONTACT: Morgan & Morgan
         Peter Safirstein, Esq.
         28 West 44th Street
         Suite 2001
         New York, NY  10036
         1-800-631-6234
         info@morgansecuritieslaw.com
 
Press spacebar to pause and continue. Press esc to stop.